SKYEPHARMA TO PRESENT AT SACHS ASSOCIATES
7TH ANNUAL BIOTECH INVESTOR IN EUROPE CONFERENCE
LONDON, UK, 25 September 2007-- SkyePharma PLC (LSE: SKP) announces today that
the Company's Chief Operating Officer, Dr Ken Cunningham, will make a
presentation at the Sachs Associates 7th Annual Biotech Investor in Europe
Conference in Zurich. Dr Cunningham will deliver his presentation on Tuesday 2
October 2007 at 3.35 p.m. CEST (2.35 p.m. UK). Investors may access the slide
presentation at www.skyepharma.com under the Investor Relations tab.
For further information please contact:
SkyePharma PLC Frank Condella +44 20 7491 1777
Ken Cunningham
Peter Grant
Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113
Deborah Scott
Trout Group (US Enquiries) Christine Labaree +1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has eleven approved products in the areas of oral,
inhalation and topical delivery that are marketed throughout the world by
leading pharmaceutical companies.
For more information, visit www.skyepharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
SkyePharma PLC announces Sachs Biotech Conference
| Source: SkyePharma PLC
London, UK--(Marketwire - September 25, 2007) -